130 related articles for article (PubMed ID: 38058049)
1. [NTRK-rearranged spindle cell neoplasm: report of a case].
Wei X; Wu HY; Pu XH; Wang XD; Li ZW; Sun Q
Zhonghua Bing Li Xue Za Zhi; 2023 Dec; 52(12):1278-1280. PubMed ID: 38058049
[TBL] [Abstract][Full Text] [Related]
2. Expanding the Spectrum of Adult NTRK3-Rearranged Spindle Cell Neoplasms: A Recurrent NTRK3-SQSTM1 Fusion Spindle Cell Tumor With Deceptively Bland Morphology.
Punjabi LS; Sittampalam K
Am J Clin Pathol; 2022 Apr; 157(4):485-493. PubMed ID: 34661642
[TBL] [Abstract][Full Text] [Related]
3. Primary NTRK-rearranged spindle cell neoplasm of bone harboring an HMBOX1::NTRK3 gene fusion.
Wang Z; Wang J
Genes Chromosomes Cancer; 2023 Aug; 62(8):477-482. PubMed ID: 36740981
[TBL] [Abstract][Full Text] [Related]
4. [NTRK-rearranged uterine sarcoma: a clinicopathological analysis of seven cases].
Huang HJ; Wang C; Fan DG; He YH; Chen X; Zheng SL
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):189-191. PubMed ID: 38281791
[No Abstract] [Full Text] [Related]
5. NTRK-rearranged spindle cell neoplasms: a clinicopathological and molecular study of 13 cases with peculiar characteristics at one of the largest institutions in China.
Yin L; Shi C; He X; Qiu Y; Chen H; Chen M; Zhang Z; Chen Y; Zhou Y; Zhang H
Pathology; 2023 Apr; 55(3):362-374. PubMed ID: 36641377
[TBL] [Abstract][Full Text] [Related]
6. Myxoid Spindle Cell Sarcoma With
So YK; Chow C; To KF; Chan JKC; Cheuk W
Int J Surg Pathol; 2020 Aug; 28(5):574-578. PubMed ID: 32050835
[TBL] [Abstract][Full Text] [Related]
7. NTRK-rearranged mesenchymal tumour with epithelioid features: expanding the morphological spectrum of NTRK-fused neoplasms.
Alves de Castro JV; D'Almeida Costa F; Torrezan GT; Carraro DM; Nicolau UR; do Nascimento AG
Histopathology; 2022 Mar; 80(4):736-739. PubMed ID: 34403526
[No Abstract] [Full Text] [Related]
8. Detection of
Solomon JP; Hechtman JF
Cancer Res; 2019 Jul; 79(13):3163-3168. PubMed ID: 31196931
[TBL] [Abstract][Full Text] [Related]
9. NTRK-rearranged spindle cell neoplasm of the lower extremity: radiologic-pathologic correlation.
Overfield CJ; Edgar MA; Wessell DE; Wilke BK; Garner HW
Skeletal Radiol; 2022 Aug; 51(8):1707-1713. PubMed ID: 35031835
[TBL] [Abstract][Full Text] [Related]
10. Adult NTRK-rearranged spindle cell neoplasms of the viscera: with an emphasis on rare locations and heterologous elements.
Tsai JW; Lee JC; Hsieh TH; Huang SC; Lee PH; Liu TT; Kao YC; Chang CD; Weng TF; Li CF; Lin JC; Liang CW; Su YL; Chang IY; Wang YT; Chang NY; Yu SC; Wang JC; Huang HY
Mod Pathol; 2022 Jul; 35(7):911-921. PubMed ID: 35149769
[TBL] [Abstract][Full Text] [Related]
11. Detection of NTRK fusions in glioblastoma: fluorescent in situ hybridisation is more useful than pan-TRK immunohistochemistry as a screening tool prior to RNA sequencing.
Bourhis A; Caumont C; Quintin-Roué I; Magro E; Dissaux G; Remoué A; Le Noac'h P; Douet-Guilbert N; Seizeur R; Tyulyandina A; Schick U; Merlio JP; Marcorelles P; Cappellen D; Uguen A
Pathology; 2022 Feb; 54(1):55-62. PubMed ID: 34518039
[TBL] [Abstract][Full Text] [Related]
12. A rare case of spindle cell neoplasm with NTRK-fusion in central nervous system.
Gong H; Gao K; Mao P; Ma S; Zhao D; Bian Y; Liu R; Gao L; Duan Q; Zhang Q; Tan Y; Wang T
Pathol Int; 2023 Jan; 73(1):52-54. PubMed ID: 35900013
[No Abstract] [Full Text] [Related]
13. Clinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC).
Chu YH; Dias-Santagata D; Farahani AA; Boyraz B; Faquin WC; Nosé V; Sadow PM
Mod Pathol; 2020 Nov; 33(11):2186-2197. PubMed ID: 32457407
[TBL] [Abstract][Full Text] [Related]
14. NTRK-Rearranged soft tissue neoplasms: A review of evolving diagnostic entities and algorithmic detection methods.
Surrey LF; Davis JL
Cancer Genet; 2022 Jan; 260-261():6-13. PubMed ID: 34794069
[TBL] [Abstract][Full Text] [Related]
15. Broadening the spectrum of NTRK rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry for identification of NTRK fusions.
Brčić I; Godschachner TM; Bergovec M; Igrec J; Till H; Lackner H; Scheipl S; Kashofer K; Brodowicz T; Leithner A; Szkandera J; Liegl-Atzwanger B
Mod Pathol; 2021 Feb; 34(2):396-407. PubMed ID: 32860002
[TBL] [Abstract][Full Text] [Related]
16. A systematic comparison of pan-Trk immunohistochemistry assays among multiple cancer types.
Haberecker M; Töpfer A; Melega F; Moch H; Pauli C
Histopathology; 2023 Jun; 82(7):1003-1012. PubMed ID: 36759438
[TBL] [Abstract][Full Text] [Related]
17. Pan-tumor screening for NTRK gene fusions using pan-TRK immunohistochemistry and RNA NGS fusion panel testing.
Koehne de González A; Mansukhani MM; Fernandes H; Hsiao SJ
Cancer Genet; 2022 Apr; 262-263():47-52. PubMed ID: 35007853
[TBL] [Abstract][Full Text] [Related]
18. NTRK Fusions Define a Novel Uterine Sarcoma Subtype With Features of Fibrosarcoma.
Chiang S; Cotzia P; Hyman DM; Drilon A; Tap WD; Zhang L; Hechtman JF; Frosina D; Jungbluth AA; Murali R; Park KJ; Soslow RA; Oliva E; Iafrate AJ; Benayed R; Ladanyi M; Antonescu CR
Am J Surg Pathol; 2018 Jun; 42(6):791-798. PubMed ID: 29553955
[TBL] [Abstract][Full Text] [Related]
19. Cytomorphologic features of NTRK-rearranged thyroid carcinoma.
Viswanathan K; Chu YH; Faquin WC; Sadow PM
Cancer Cytopathol; 2020 Nov; 128(11):812-827. PubMed ID: 33074583
[TBL] [Abstract][Full Text] [Related]
20. Limited Accuracy of Pan-Trk Immunohistochemistry Screening for
Macerola E; Proietti A; Poma AM; Vignali P; Sparavelli R; Ginori A; Basolo A; Elisei R; Santini F; Basolo F
Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
